Page last updated: 2024-08-26

bosentan anhydrous and Escherichia coli Infections

bosentan anhydrous has been researched along with Escherichia coli Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hemsén, A; Lundberg, JM; Rudehill, A; Wanecek, M; Weitzberg, E	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Escherichia coli Infections

Article	Year
The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock. Critical care medicine, 1997, Volume: 25, Issue:5 Topics: Animals; Bosentan; Cyclooxygenase Inhibitors; Diclofenac; Drug Therapy, Combination; Endothelin Receptor Antagonists; Escherichia coli Infections; Hemodynamics; Hypertension, Pulmonary; Renal Circulation; Shock, Septic; Sulfonamides; Swine	1997

Article

Year

The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock.

Critical care medicine, 1997, Volume: 25, Issue:5

Topics: Animals; Bosentan; Cyclooxygenase Inhibitors; Diclofenac; Drug Therapy, Combination; Endothelin Receptor Antagonists; Escherichia coli Infections; Hemodynamics; Hypertension, Pulmonary; Renal Circulation; Shock, Septic; Sulfonamides; Swine

1997